ClinicalTrials.Veeva

Menu

Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus

University of Kansas logo

University of Kansas

Status

Completed

Conditions

Type 2 Diabetes

Treatments

Behavioral: Time Restricted Eating (TRE)
Behavioral: Intermittent energy restriction (IER)

Study type

Interventional

Funder types

Other

Identifiers

NCT05860413
STUDY00149127

Details and patient eligibility

About

To test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.

Full description

Intermittent energy restriction (IER) and time-restricted eating (TRE) are two distinct forms of intermittent fasting which have yet to be compared for the treatment of type 2 diabetes. Investigators will test whether a comprehensive, intensive lifestyle program featuring each of these intermittent fasting approaches is feasible and effective for improving glycemic control in patients diagnosed with type 2 diabetes within the past 10 years. Both interventions will be delivered over one year in three phases: (1) a 12-week weight loss program featuring weekly group meetings, (2) a 12-week weight maintenance program featuring biweekly group meetings, and (3) a 6-month low-contact follow up period featuring monthly check-ins.

Enrollment

57 patients

Sex

All

Ages

21 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosed with type 2 diabetes in the past 10 years.
  2. Age 21-65 years
  3. BMI of 25 - 45 kg/m2
  4. HbA1c of 6.7-9.5%, or those with A1c of <6.7% on glucose-lowering medications
  5. Ability to participate in a graduated physical activity program
  6. Clearance from study physician.

Exclusion criteria

  1. Inability to attend health education meetings.
  2. Weight change of >=5% in the previous 3 months.
  3. Addition of new antihyperglycemic or weight-reducing medication in the previous 2 months.
  4. Serious medical risk such as ongoing treatment for cancer, uncontrolled hypertension, recent cardiac event, or other medical condition presenting acute risk of participation in a lifestyle change program.
  5. Untreated depression or anxiety, or increase in associated medications in the previous 3 months.
  6. Current participation in another lifestyle change intervention, such as a tobacco cessation program or physical activity program.
  7. Pregnancy or lactation within the previous six months
  8. Weight of >450 lbs
  9. Currently taking medications that may result in hypoglycemia during fasting and unwilling to stop prior to the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

57 participants in 2 patient groups

Intermittent energy restriction (IER)
Experimental group
Description:
Intermittent fasting using a very-low energy diet (VLED; 550-800 kcal/d) 2-3 days per week
Treatment:
Behavioral: Intermittent energy restriction (IER)
Time-restricted eating (TRE)
Experimental group
Description:
Intermittent fasting using an 8-hour eating period.
Treatment:
Behavioral: Time Restricted Eating (TRE)

Trial contacts and locations

1

Loading...

Central trial contact

Annie Eller, RD; Felicia Steger, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems